ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS.
作者信息
Scullion T, Gorman P, Gibson E, Kelly R, Murtagh E, Minnis P
机构信息
Interstitial Lung Disease Service: Respiratory Medicine, Antrim Area Hospital, Bush Road BT41 2RL.
出版信息
Ulster Med J. 2017 Jan;86(1):73.
Abstract
摘要
相似文献
1
ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS.特发性肺纤维化的抗纤维化治疗
Ulster Med J. 2017 Jan;86(1):73.
2
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.特发性肺纤维化中使用抗纤维化药物过渡到肺移植的安全性和有效性：病例系列
BMC Pulm Med. 2016 Nov 18;16(1):156. doi: 10.1186/s12890-016-0308-z.
3
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence.抗纤维化治疗时代的特发性肺纤维化：基于证据寻找新机遇。
Rev Port Pneumol (2006). 2017 Sep-Oct;23(5):287-293. doi: 10.1016/j.rppnen.2017.05.005. Epub 2017 Jun 28.
4
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.吡非尼酮和泼尼松龙的抗纤维化作用：对博来霉素诱导的小鼠肺纤维化中肺细胞因子和生长因子的不同影响
Eur J Pharmacol. 2008 Aug 20;590(1-3):400-8. doi: 10.1016/j.ejphar.2008.06.046. Epub 2008 Jun 16.
5
Use of tacrolimus, a potent antifibrotic agent, in bleomycin-induced lung fibrosis.强效抗纤维化药物他克莫司在博来霉素诱导的肺纤维化中的应用。
Eur Respir J. 2006 Mar;27(3):460-9. doi: 10.1183/09031936.06.00070705.
6
A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis.环氧化酶-2基因的一个单倍型与特发性肺纤维化相关。
Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):121-30.
7
Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosis.干扰素γ-1b在肺纤维化中的抗纤维化作用机制
Wien Klin Wochenschr. 2000 Sep 29;112(18):785-90.
8
Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.吡非尼酮开创特发性肺纤维化治疗新纪元。
Annu Rev Med. 2016;67:487-95. doi: 10.1146/annurev-med-120214-013614. Epub 2015 Nov 4.
9
Developments in the management of idiopathic pulmonary fibrosis.特发性肺纤维化的管理进展
Drug Ther Bull. 2015 Jul;53(7):78-81. doi: 10.1136/dtb.2015.7.0337.
10
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.吡非尼酮治疗特发性肺纤维化（CAPACITY）患者的两项随机试验。
Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13.
引用本文的文献
1
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.进展性肺纤维化性间质性肺疾病的药物治疗管理：当前证据综述。
Eur Respir Rev. 2018 Dec 21;27(150). doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31.
2
Proteases Revisited: Roles and Therapeutic Implications in Fibrosis.再谈蛋白酶：在纤维化中的作用及治疗意义
Mediators Inflamm. 2017;2017:2570154. doi: 10.1155/2017/2570154. Epub 2017 May 31.
本文引用的文献
1
Therapeutic advances in idiopathic pulmonary fibrosis.特发性肺纤维化的治疗进展
Clin Med (Lond). 2016 Feb;16(1):42-51. doi: 10.7861/clinmedicine.16-1-42.
Zotero 插件